# Study of Metformin and S. Baicalensis Combination Therapy in Type 2 Diabetes Mellitus Patients

> **NCT02844803** · EARLY_PHASE1 · UNKNOWN · sponsor: **Namyi Gu** · enrollment: 20 (estimated)

## Conditions studied

- Diabetes Mellitus

## Interventions

- **DRUG:** Combination of Metformin + S. Baicalensis
- **DRUG:** Combination of Metformin + Placebo

## Key facts

- **NCT ID:** NCT02844803
- **Lead sponsor:** Namyi Gu
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-07
- **Primary completion:** 2017-06
- **Final completion:** —
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2016-08-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02844803

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02844803, "Study of Metformin and S. Baicalensis Combination Therapy in Type 2 Diabetes Mellitus Patients". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02844803. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*